Healthcare & Life Sciences Industry Updates

Google News – Clinical Trials External News

Retaining Patients For 13+ Years In DIAD Research - Clinical Leader

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Researchers looking into whether GLP-1 drugs can help slow aging - Yahoo

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma | Newswise - Newswise

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

TIL Therapy Clinical Trial Pipeline Appears Robust With 17+ - GlobeNewswire

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

NORROY BIOSCIENCE Granted FDA Breakthrough Therapy and Fast Track Designations for Kidney Cancer Imaging Product - Fidelity Investments

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Galmed Announces Successful First-in-Human Proof-of-Concept Clinical Study Results for Colospan's Novel Intraoperative Tissue Assessment Technology - PR Newswire

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Merck, Moderna Post Positive Phase 3 Melanoma Vaccine Data - Mexico Business News

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

New Trials Signal ‘Historic Moment’ for Progressive Supranuclear Palsy - beingpatient.com

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

What Patients Should Know About Expanded Access Programs - Choteau Acantha

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Is a Cancer Vaccine on the Horizon? Merck and Moderna Hope So - HowStuffWorks

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

A new technology measured colon tissue in all 32 patients with no failures - Stock Titan

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Moderna Shares Surge 150% on Positive mRNA Cancer Vaccine Results - ColombiaOne.com

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Interactive: A cancer vaccine is being tailored to individuals - fox13now.com

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients With Completely Resected Stage IIB-IV Melanoma - Investing News Network

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Ultragenyx Receives FDA Accelerated Approval for GENGLYCOS Gene Therapy for GSDIa - quiverquant.com

news.google.com · 20 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Retaining Patients For 13+ Years In DIAD Research - Clinical Leader

Researchers looking into whether GLP-1 drugs can help slow aging - Yahoo

Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma | Newswise - Newswise

TIL Therapy Clinical Trial Pipeline Appears Robust With 17+ - GlobeNewswire

NORROY BIOSCIENCE Granted FDA Breakthrough Therapy and Fast Track Designations for Kidney Cancer Imaging Product - Fidelity Investments

Galmed Announces Successful First-in-Human Proof-of-Concept Clinical Study Results for Colospan's Novel Intraoperative Tissue Assessment Technology - PR Newswire

Merck, Moderna Post Positive Phase 3 Melanoma Vaccine Data - Mexico Business News

New Trials Signal ‘Historic Moment’ for Progressive Supranuclear Palsy - beingpatient.com

What Patients Should Know About Expanded Access Programs - Choteau Acantha

Is a Cancer Vaccine on the Horizon? Merck and Moderna Hope So - HowStuffWorks

A new technology measured colon tissue in all 32 patients with no failures - Stock Titan

Moderna Shares Surge 150% on Positive mRNA Cancer Vaccine Results - ColombiaOne.com

Interactive: A cancer vaccine is being tailored to individuals - fox13now.com

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients With Completely Resected Stage IIB-IV Melanoma - Investing News Network

Ultragenyx Receives FDA Accelerated Approval for GENGLYCOS Gene Therapy for GSDIa - quiverquant.com